| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 08/23/2006 | CN1822824A Method of treating degenerative disc disease |
| 08/23/2006 | CN1820772A Medicine for treating rheumatic arthritis and its preparing method |
| 08/23/2006 | CN1820741A Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 08/23/2006 | CN1271030C Process for synthesis of cis-1-2-4-(6-methoxy-2-phenyl-1,2,3,4- tetrahydronaphthalen-1-yl)-phenoxy-ethyl-pyrrolidine |
| 08/23/2006 | CN1270766C Externally applied plaster for treating hyperosteogeny and preparation method thereof |
| 08/23/2006 | CN1270755C Pharmaceutical composition for treating rheumatic arthritis and rheumatoid arthritis |
| 08/23/2006 | CN1270749C Bone impediment convalescence capsule |
| 08/23/2006 | CN1270745C Chinese kmedicine bolus for treating femoral head necrosis and its prepn process |
| 08/23/2006 | CN1270743C Chinese traditional medicine for treating prolapse of lumbar intervertebral disc |
| 08/23/2006 | CN1270737C Drug for treating gout and method for preparing pill thereof |
| 08/23/2006 | CN1270704C Application of combination of L-lysine, dimethylamino tetracycline hydrochloride and metronidazole |
| 08/22/2006 | US7094916 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 08/22/2006 | US7094911 Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
| 08/22/2006 | US7094802 PKB-3564 substance with neovascularization inhibitory activity |
| 08/22/2006 | US7094801 Inhibiting the expression of VCAM-1; treating inflammatory disorders including rheumatoid arthritis, atherosclerosis, COPD, asthma, allergic rhinitis and restinosis |
| 08/22/2006 | US7094797 Organ fibrosis inhibitor |
| 08/22/2006 | US7094779 2-(3-indolylmethyl)-1-benzoyl-4-oxime-piperazine derivatives, e.g., 1-{(2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(1H-indol-3-ylmethyl)-piperazin-4-yl}-2-propanone O-[2-(dimethylamino)-ethyl]oxime, used for treatment of CNS disorders. |
| 08/22/2006 | US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets |
| 08/22/2006 | US7094773 LTA4 hydrolase inhibitors |
| 08/22/2006 | US7094772 Phosphonate compounds |
| 08/22/2006 | US7094549 mass spectroscopy; medical diagnosis/prognosis; kits |
| 08/17/2006 | WO2006085692A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/17/2006 | WO2006084757A2 Combination of ca/mg salt of valsartan with an antidiabetic agent |
| 08/17/2006 | WO2006064381A3 Protein formulation |
| 08/17/2006 | WO2006063974A3 Il-15 antigen arrays and uses thereof |
| 08/17/2006 | WO2006054921A3 Anti-inflammatory extract and agent and method for the production thereof |
| 08/17/2006 | WO2006045578A3 Process for the preparation of ibandronate |
| 08/17/2006 | WO2005115363A3 Method for treating skeletal disorders resulting from fgfr malfunction |
| 08/17/2006 | WO2003053346A3 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/17/2006 | US20060183778 Osteogenesis-promotion enhancer and method of screening the same |
| 08/17/2006 | US20060183770 Sulfonamide derivative having isoxazole ring |
| 08/17/2006 | US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 08/17/2006 | US20060183755 Tyrosine kinase inhibitors |
| 08/17/2006 | US20060183731 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity |
| 08/17/2006 | US20060183717 Process for treating lameness with an osseous, articular or osteoarticular component in human or veterinary medicine, comprising the administration of a bisphosphonic acid derivative |
| 08/17/2006 | US20060183664 Pharmaceutical composition for delayed hypersensitivity |
| 08/17/2006 | US20060182809 System for transporting active substances in a biological system |
| 08/17/2006 | US20060182720 Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof |
| 08/17/2006 | CA2597541A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/16/2006 | EP1690932A1 Bone and/or joint disease-associated gene |
| 08/16/2006 | EP1690874A2 BMP-12, BMP-13 and tendon-inducing compositions thereof |
| 08/16/2006 | EP1690864A2 Tricyclic purine compounds and their analogs as inhibitors of cytokine signalling |
| 08/16/2006 | EP1690538A1 Isoxazole derivative having agonistic activity against peroxisome proliferator-activated receptor |
| 08/16/2006 | EP1689759A1 Method for producing pure disodium pamidronate |
| 08/16/2006 | EP1689744A1 Antiresorptive mutual salt of raloxifene and bisphosphonic acid |
| 08/16/2006 | EP1689436A1 TREATMENT OF RHEUMATOID ARTHRITIS WITH HYPOXIA-INDUCIBLE FACTOR a ANTAGONISTS |
| 08/16/2006 | EP1689427A1 Biomarkers for the efficacy of calcitonin and parathyroid hormone treatment |
| 08/16/2006 | EP1513835B1 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/16/2006 | EP1377282B1 Aryl-n-cyanoguanidines and methods related thereto |
| 08/16/2006 | EP1318991B1 Benzoic acid derivatives and uses thereof |
| 08/16/2006 | EP1259234B1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 08/16/2006 | EP1183020B1 (3-trihalomethylphenoxy) (4-halophenyl) for the treatment of insulin resistance and type 2 diabetes |
| 08/16/2006 | EP1165490B1 Substituted 2-aminobenzamide caspase inhibitors and the use thereof |
| 08/16/2006 | EP1137410B1 Novel 4-dedimethyl aminotetracycline derivatives |
| 08/16/2006 | EP1115876B1 Receptor based antagonists and methods of making and using |
| 08/16/2006 | EP0880523B1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/16/2006 | CN1820078A Recombinant mutants of rhabdovirus and methods of use thereof |
| 08/16/2006 | CN1820011A Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 08/16/2006 | CN1820001A Substituted heterocyclic diarylamine analogues |
| 08/16/2006 | CN1819833A Hgf production accelerator containing heparin-like oligosaccharide |
| 08/16/2006 | CN1817854A Amino acids with affinity for the alpha-2-delta protein |
| 08/16/2006 | CN1817366A Medicinal composition for treating rheumatosis and preparation thereof |
| 08/16/2006 | CN1817363A Medicine for treating various diseases |
| 08/16/2006 | CN1817348A Medicinal composition with glycosamine hydrochloride and cartilagin sulfate as active components, its preparation and use thereof |
| 08/16/2006 | CN1269960C Human FGF23 protein mutant lowering blood phosphorus level |
| 08/16/2006 | CN1269942C Hops extracts, method for prodn. and use |
| 08/16/2006 | CN1269836C Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 08/16/2006 | CN1269820C Novel pyrrole derivatives as pharmaceutical agents |
| 08/16/2006 | CN1269813C Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation |
| 08/16/2006 | CN1269804C Metalloproteinase inhibitors |
| 08/16/2006 | CN1269519C Capsule of activating the channels for cervical vertebrae |
| 08/16/2006 | CN1269504C Medicine for treating rheumatic and rheumatoid arthritis |
| 08/16/2006 | CN1269494C Medicine for treating numbness and preparing method thereof |
| 08/15/2006 | USRE39239 Methods for treating early morning pathologies |
| 08/15/2006 | US7091380 Bradykinin B1 antagonists or inverse agonists, for prophylaxis and therapy of pain and inflammation |
| 08/15/2006 | US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal |
| 08/15/2006 | US7091353 Isoindole-imide compounds, compositions, and uses thereof |
| 08/15/2006 | US7091352 Antiinflammatory agents; analgesics; antiarthritic agents |
| 08/15/2006 | US7091347 2-substituted amino-bicyclic pyridine and pyrimidine compounds; for treatment of inflammation, inflammatory bowel disease, Alzheimer's disease, Crohn's disease, multiple sclerosis and asthma |
| 08/15/2006 | US7091343 Compositions useful as inhibitors of protein kinases |
| 08/15/2006 | US7091232 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds |
| 08/15/2006 | US7091227 Serine/threonine and tyrosine kinases inhibitors |
| 08/15/2006 | US7091224 Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 08/15/2006 | US7091223 Autoimmune diseases; anticancer agents |
| 08/15/2006 | US7091215 Corticotropin-Releasing Factor (CRF) receptor antagonist |
| 08/15/2006 | US7091213 Phosphorus-containing compounds and uses thereof |
| 08/15/2006 | US7091208 Janus Kinase inhibitors and optionally mixed with antiinflammatory agents, for use as immunosuppresants for prophylaxis of lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, diabetes and graft versus host diseases |
| 08/15/2006 | US7091204 Sulfonamides |
| 08/15/2006 | US7091187 Using steroid; autoimmune disease |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity |
| 08/15/2006 | CA2107439C Phospholipid derivatives containing phosphorous, arsenic, antimony or bismuth |
| 08/10/2006 | WO2006083687A1 Crystal salt of xanthine oxidase inhibitors |
| 08/10/2006 | WO2006083673A2 Pyridine derivatives useful as inhibitors of c-jun n-terminal kinases |
| 08/10/2006 | WO2006083454A1 Multicyclic bis-amide mmp inhibitors |
| 08/10/2006 | WO2006082975A1 Optically active tetrahydronaphthalene derivative |
| 08/10/2006 | WO2006082952A1 Amide compound |
| 08/10/2006 | WO2006082077A1 Natural remedy-dietary supplement combination product |
| 08/10/2006 | WO2006082072A1 Use of active ingredients containing hydroxystilbene for preventing and/or treating osteoporosis |